ClinicalTrials.gg
RecruitingNCT07759193Updated Sep 16, 2026

Energy Expenditure Assessment in Head and Neck Cancer Patients Treated With Free Flap Surgery

An interventional study of Indirect Calorimetry (Diagnostic Test) in Reconstructive Surgical Procedures, Free Tissue Flaps and Head and Neck Cancer, sponsored by Tel-Aviv Sourasky Medical Center. Recruiting at 1 site in Israel. Open to participants aged 18 Years to 120 Years. Per ClinicalTrials.gov, last updated 2026-09-16.

Sponsored by Tel-Aviv Sourasky Medical Center · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 1 year 7 months after the study started (first participant enrolled Jan 2025, registered Aug 2026).
  • Started Jan 2025; still recruiting 1 year 10 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
19
Allocation
Not applicable
Ages
18 Years to 120 Years
Sex
All
01

Study summary

What is the purpose of this study?

Patients with head and neck cancer who undergo surgery with free flap reconstruction often need careful nutritional support during recovery. The purpose of this study is to better understand how much energy (calories) these patients need before and after surgery and whether nutrition is related to recovery, complications, and overall outcomes.

Who can participate?

Adults (18 years and older) with head and neck cancer who are scheduled to undergo free flap reconstructive surgery at Tel Aviv Sourasky Medical Center may be invited to participate.

What will participants do?

Participants will undergo several nutrition-related assessments before and after surgery, including:

Indirect calorimetry tests, which measure how much energy the body uses. Body composition measurements using a non-invasive device. A questionnaire about food intake. Collection of routine clinical information, laboratory results, and recovery data from medical records.

The indirect calorimetry assessments will be performed before surgery, several days after surgery, before hospital discharge, and approximately one month after discharge.

What are the possible benefits of the study?

The information obtained may help researchers better understand the nutritional needs of patients with head and neck cancer undergoing major surgery. This knowledge may improve nutritional care and recovery for future patients.

Will participation affect medical care?

Participation in the study will not change the standard medical or nutritional care patients receive. Nutritional follow-up will continue according to routine clinical practice.

How will privacy be protected?

Study data will be stored in a coded form, and access will be limited to authorized study personnel. Personal identifying information will be kept separate from the research database.

02

Conditions studied

  • Reconstructive Surgical Procedures
  • Free Tissue Flaps
  • Head and Neck Cancer
  • Perioperative Care
03

In context

Head and Neck Neoplasms

2,710 studies on the registry are indexed under Head and Neck Neoplasms; 594 are open to participants now.

This study's planned enrollment of 19 is below the median of 46 across 2,032 interventional studies indexed under Head and Neck Neoplasms.

Browse Head and Neck Neoplasms studies →

Lead sponsor

Tel-Aviv Sourasky Medical Center is the lead sponsor of 554 studies on the registry; 51 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 120 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged 18 years or older.
  • Diagnosis of head and neck cancer.
  • Scheduled to undergo or have undergone free flap reconstruction surgery at Tel Aviv Sourasky Medical Center.
  • Availability of indirect calorimetry measurements, nutritional data, postoperative -complications data, and follow-up information.
  • Ability and willingness to provide .

Exclusion criteria

Exclusion Criteria:

  • Age younger than 18 years.
  • Pregnant women.
  • Individuals unable to provide .
  • Vulnerable populations as defined by local regulations.
  • Death before completion of study assessments.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
19 participants (estimated)

Study arms

  • Experimental
    Free Flap Reconstruction Cohort

    Device: Indirect Calorimetry (Diagnostic Test)

Interventions

  • DeviceIndirect Calorimetry (Diagnostic Test)

    indirect calorimetry will be used to measure resting energy expenditure in adult patients with head and neck cancer undergoing free flap reconstruction surgery. Assessments will be performed before surgery, several days after surgery, before hospital discharge, and approximately one month after discharge. The results will be used to characterize patients' energy requirements and nutritional profile throughout the perioperative period.

06

What researchers measure

Primary outcomes

  1. Energy expenditure measured by indirect calorimetry.

    Measured energy expenditure compared with ESPEN nutritional recommendations for oncology patients.

    Time frame: From baseline (pre-surgery) to approximately 1 month after hospital discharge

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 16, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07759193
Responsible party
Shmuel Kivity, MD (MD, Tel-Aviv Sourasky Medical Center) — Principal investigator
First posted
Aug 12, 2026
Start date
Jan 1, 2025
Primary completion
Dec 1, 2026 (estimated)
Completion
Dec 30, 2026 (estimated)
Last update
Sep 16, 2026

Study contacts

Anton Waeshavsky MD
Contact
anton.warshavsky@gmail.com
+972505628629

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion